14-34711471-AT-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_138638.5(CFL2):c.*1393del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.76 ( 44987 hom., cov: 0)
Exomes 𝑓: 0.74 ( 84848 hom. )
Consequence
CFL2
NM_138638.5 3_prime_UTR
NM_138638.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.527
Genes affected
CFL2 (HGNC:1875): (cofilin 2) This gene encodes an intracellular protein that is involved in the regulation of actin-filament dynamics. This protein is a major component of intranuclear and cytoplasmic actin rods. It can bind G- and F-actin in a 1:1 ratio of cofilin to actin, and it reversibly controls actin polymerization and depolymerization in a pH-dependent manner. Mutations in this gene cause nemaline myopathy type 7, a form of congenital myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 14-34711471-AT-A is Benign according to our data. Variant chr14-34711471-AT-A is described in ClinVar as [Benign]. Clinvar id is 313083.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.796 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFL2 | NM_138638.5 | c.*1393del | 3_prime_UTR_variant | 4/4 | ENST00000298159.11 | NP_619579.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFL2 | ENST00000298159.11 | c.*1393del | 3_prime_UTR_variant | 4/4 | 1 | NM_138638.5 | ENSP00000298159 | P1 | ||
CFL2 | ENST00000341223.8 | c.*1393del | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000340635 | P1 | |||
CFL2 | ENST00000672517.1 | c.*1393del | 3_prime_UTR_variant | 5/5 | ENSP00000500532 | P1 |
Frequencies
GnomAD3 genomes AF: 0.762 AC: 115909AN: 152014Hom.: 44969 Cov.: 0
GnomAD3 genomes
AF:
AC:
115909
AN:
152014
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.696 AC: 95075AN: 136634Hom.: 35078 AF XY: 0.710 AC XY: 52676AN XY: 74178
GnomAD3 exomes
AF:
AC:
95075
AN:
136634
Hom.:
AF XY:
AC XY:
52676
AN XY:
74178
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.738 AC: 223077AN: 302226Hom.: 84848 Cov.: 0 AF XY: 0.743 AC XY: 128055AN XY: 172254
GnomAD4 exome
AF:
AC:
223077
AN:
302226
Hom.:
Cov.:
0
AF XY:
AC XY:
128055
AN XY:
172254
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.762 AC: 115978AN: 152128Hom.: 44987 Cov.: 0 AF XY: 0.757 AC XY: 56297AN XY: 74388
GnomAD4 genome
AF:
AC:
115978
AN:
152128
Hom.:
Cov.:
0
AF XY:
AC XY:
56297
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Nemaline Myopathy, Recessive Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at